Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    GMP for Phase I Investigational Drug Products 2018

    View: 228

    Website http://www.compliance4all.com/control/w_product/~product_id=501683LIVE?channel=ourglocal_Mar_2018_SE | Want to Edit it Edit Freely

    Category Clinical Trials, Good Manufacturing Practices, compliance procedures, clinical compliance training, usp good documentation practices, Specialists courses

    Deadline: March 21, 2018 | Date: March 22, 2018

    Venue/Country: Online, U.S.A

    Updated: 2018-01-30 16:19:18 (GMT+9)

    Call For Papers - CFP

    Overview:

    Phase I clinical trials are the first time that investigational new drugs are introduced into human subjects and, although it is very, very important for all drugs to be manufactured using GMPs, it is probably more important than at any other time during the lifecycle of the product, that a product be safe whenever humans are being exposed to it for the first time.

    Why should you Attend:

    FDAs guidance document "Good Manufacturing Practice for Phase I Investigational Drug Products" applies to correct GMP requirements to drug products made for the purpose of using an investigational drug product on human subjects for the first time, during conduct of Phase I clinical trials, which can begin if your IND is not put on clinical hold in 30 days after receipt by the FDA.

    Areas Covered in the Session:

    Statutory and Regulatory Requirements

    Personnel requirements

    QC Functions

    Facility and Equipment Requirements

    Control of Components and Containers and Closures

    Manufacturing and Records

    Who Will Benefit:

    Senior Quality Managers, Quality VPs

    Quality Associates or Specialists

    Regulatory Management or Regulatory Specialists

    Compliance Professionals

    Speaker Profile:

    Stephanie Cooke is the President/CEO of Cooke Consulting, Inc. Stephanie uses her roughly 20 years of experience to provide global consulting services in various areas of Regulatory Affairs, Quality Assurance and validation for pharmaceutical, biological/biotech products, medical device, combination drug/device and nutraceutical firms.

    Event Fee: One Dial-in One Attendee Price: US$150.00

    Contact Detail:

    Compliance4All DBA NetZealous,

    Phone: +1-800-447-9407

    Email: supportatcompliance4All.com


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.